医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
36期
275-276,277
,共3页
婴幼儿%肺炎支原体肺炎%喘息
嬰幼兒%肺炎支原體肺炎%喘息
영유인%폐염지원체폐염%천식
children%mycoplasma pneumonia%breathing
分析婴幼儿肺炎支原体肺炎并喘息的治疗效果。方法:选取我院收治的肺炎支原体肺炎并喘息患400例,按照数字随机法,随机将其分成实验组和对照组,对照组采取阿奇霉素序贯疗法联合布地奈德雾化吸入治疗,实验组采取阿奇霉素序贯疗法、布地奈德雾化吸入联合特布他林治疗,比较两组临床疗效。结果:实验组总有效率明显高于对照组,差异有统计学意义(P<0.05)。实验组咳嗽平均消失时间、平均住院时间均短于对照组,差异有统计学意义(P<0.05)。结论:阿奇霉素序贯疗法联合布地奈德雾化吸入、特布他林治疗小儿肺炎支原体肺炎具有显著的临床疗效,患儿症状缓解较快,临床价值较高。
分析嬰幼兒肺炎支原體肺炎併喘息的治療效果。方法:選取我院收治的肺炎支原體肺炎併喘息患400例,按照數字隨機法,隨機將其分成實驗組和對照組,對照組採取阿奇黴素序貫療法聯閤佈地奈德霧化吸入治療,實驗組採取阿奇黴素序貫療法、佈地奈德霧化吸入聯閤特佈他林治療,比較兩組臨床療效。結果:實驗組總有效率明顯高于對照組,差異有統計學意義(P<0.05)。實驗組咳嗽平均消失時間、平均住院時間均短于對照組,差異有統計學意義(P<0.05)。結論:阿奇黴素序貫療法聯閤佈地奈德霧化吸入、特佈他林治療小兒肺炎支原體肺炎具有顯著的臨床療效,患兒癥狀緩解較快,臨床價值較高。
분석영유인폐염지원체폐염병천식적치료효과。방법:선취아원수치적폐염지원체폐염병천식환400례,안조수자수궤법,수궤장기분성실험조화대조조,대조조채취아기매소서관요법연합포지내덕무화흡입치료,실험조채취아기매소서관요법、포지내덕무화흡입연합특포타림치료,비교량조림상료효。결과:실험조총유효솔명현고우대조조,차이유통계학의의(P<0.05)。실험조해수평균소실시간、평균주원시간균단우대조조,차이유통계학의의(P<0.05)。결론:아기매소서관요법연합포지내덕무화흡입、특포타림치료소인폐염지원체폐염구유현저적림상료효,환인증상완해교쾌,림상개치교고。
Objective: to analyze the mycoplasma pneumonia in infants and breathing treatment effect. Methods: 400 cases of Mycoplasma pneumoniae pneumonia and wheeze in our hospital were selected, according to the random number method, randomly divided into the observation group and the control group, the control group taking Azithromycin Sequential Therapy Combined with budesonide inhalation treatment, the control group took the Azithromycin Sequential therapy, aerosol inhalation of budesonide combined with terbutaline treatment, compared the clinical efficacy two groups. Results: the total effective rate of observation group is obviously higher than that of the control group, the difference was statistical y significant (P <0.05). The observation group average cough disappeared time, hospitalization time was shorter than the control group, the difference was statistical y significant (P < 0.05). Conclusion:Azithromycin Sequential Therapy Combined with inhalation of budesonide, terbutaline in the treatment of mycoplasma pneumonia in children has significant clinical efficacy, symptomatic relief faster, higher clinical value.